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3p deletion syndrome is a rare contiguous-gene disorder involving the loss of the telomeric portion of the short
arm of chromosome 3 and characterized by developmental delay, growth retardation, and dysmorphic features.
All reported cases have involved, at a minimum, the deletion of chromosome 3 telomeric to the band 3p25.3.
Despite the presence of several genes in this region that are involved in neural development, a causative relationship
between a particular transcript and the observed clinical manifestations has remained elusive. We have identiﬁed
a child with characteristic physical features of 3p deletion syndrome and both verbal and nonverbal developmental
delay who carries a de novo balanced translocation involving chromosomes 3 and 10. Fine mapping of this
rearrangement demonstrates that the translocation breakpoint on chromosome 3 falls within the recently identiﬁed
minimal candidate region for 3p deletion syndrome and disrupts the Contactin 4 (CNTN4) mRNA transcript at
3p26.2–3p26.3. This transcript (also known as BIG-2) is a member of the immunoglobulin super family of neuronal
cell adhesion molecules involved in axon growth, guidance, and fasciculation in the central nervous system (CNS).
Our results demonstrate the association of CNTN4 disruption with the 3p deletion syndrome phenotype and strongly
suggest a causal relationship. These ﬁndings point to an important role for CNTN4 in normal and abnormal CNS
development.
3p deletion syndrome is a rare contiguous-gene disorder
involving the telomeric portion of the short arm of chro-
mosome 3. Clinically, the syndrome is characterized by
developmental delay, growth retardation, and dys-
morphic features (Verjaal and De Nef 1978; Schwyzer
et al. 1987; Narahara et al. 1990; Mowrey et al. 1993;
Phipps et al. 1994; Drumheller et al. 1996; McClure et
al. 1996; Angeloni et al. 1999; Benini et al. 1999; Cargile
et al. 2002). Less commonly, renal cysts, gastrointestinal
abnormalities, and congenital heart defects have been
described. All reported cases involve, at a minimum, the
loss of chromosomal material telomeric to 3p25.3. Ter-
minal deletions involving the more centromeric regions
of 3p have been thought to predispose to cardiac septal
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defects (Brand et al. 1987; Phipps et al. 1994; Drum-
heller et al. 1996; Green et al. 2000). However, a min-
imal candidate region conferring the common features
of the syndrome has been identiﬁed recently in a patient
with an interstitial deletion involving a 4.5-Mb interval
between markers D3S3630 and D3S1304 (Cargile et al.
2002). Despite investigations of several genes in the 3p
region involved in CNS development (Angeloni et al.
1999; Endris et al. 2002; Montag-Sallaz et al. 2003;
Soderling et al. 2003), a causative relationship between
any particular transcript and the range of observed clin-
ical manifestations has remained elusive.
CT is a boy aged 7 years 11 mo with borderline in-
tellectual functioning, distinctive facial (ﬁg. 1) and other
physical features, and behavioral problems who was
seen in the Genetics Outpatient Clinic at Yale and eval-
uated under a research protocol approved by the Yale
Human Investigation Committee with informed consent.
The patient was the product of a nonconsanguineous
union, delivered at 40 wk gestation from his 29 year-
old primiparous mother by cesarean section performed
because of failure to progress. There was no history of
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Figure 1 Eight-year-old boy with developmental delay and fea-
tures of 3p deletion syndrome. The child has had surgical correction
of prominent ptosis.
alcohol consumption or medication use during preg-
nancy and no known exposure to teratogens. He had a
difﬁcult facial presentation, with mild perinatal respi-
ratory depression and an Apgar score of 3 at 1 min.
Cord blood pH was 7.28. After brief positive pressure
ventilation, his Apgar score was 9 at 5 min. Birth weight
was 3,787 g and length was 19 inches. Cytogenetic anal-
ysis was performed shortly after birth, which revealed a
balanced translocation (46, XY, t[3;10][p26;q26]) (ﬁg.
2A). Both parents had normal karyotypes. No other
family members were reported to have mental retarda-
tion or dysmorphic features.
The child’s early motor development was unremark-
able: he rolled over at 4 mo and was sitting with support
at 6.5 mo. At 7 mo, he was able to stand with assistance,
and he walked at 14 mo. His development of language,
in contrast, was markedly delayed, with the absence of
distinct single words until 3.5 years. CT underwent a
cognitive assessment at age 7 years 2 mo and was found
to have a full scale IQ of 73 on the Wechsler Intelligence
Scale for Children, Third Edition (WISC-III) (Wechsler
1992) (Mean p 100; ), which places his cog-SDp 15
nitive skills within the borderline range of intellectual
functioning. He obtained a verbal IQ of 81 and a per-
formance (or nonverbal) IQ of 70. Signiﬁcant weak-
nesses in his proﬁle related to attention to visual detail
(subtest score of 3; meanp 10, ), visual-spatialSDp 3
reconstruction skills (subtest score of 3), and under-
standing of social mores and expectations (subtest score
of 3). These deﬁcits contrasted with his signiﬁcant
strength in the area of fund of knowledge (subtest score
of 12). An assessment of adaptive functioning at age 7
years 11 mo using the Vineland Adaptive Behavior
Scales, Expanded Edition (Sparrow et al. 1984), showed
marked impairments in social functioning and daily liv-
ing skills. In the Daily Living Skills Domain, his percen-
tile rank score was !0.1, corresponding to an age equiv-
alent score of 4 years. In the Socialization Domain, his
percentile rank score was within the ﬁrst percentile, cor-
responding to an age equivalent score of 4 years 1 mo.
Taken together, these ﬁndings demonstrated develop-
mental delay, with particular deﬁcits in nonverbal
learning.
CT’s past medical history was unremarkable. He was
noted to be in excellent physical health and had required
surgery only for correction of ptosis. He had been fol-
lowed closely from a very young age by his pediatrician
as a consequence of his dysmorphic features and known
cytogenetic rearrangement and was not found to have
any evidence of GI, cardiac, or renal abnormalities on
physical exam or by history. A referral to a pediatric
neurologist for behavioral issues at age 6 years revealed
a normal neurological exam, except for the identiﬁcation
of mild hypotonia. Neither neuroimaging nor electro-
encephalogram was deemed to be clinically indicated.
Physical examination at age 7 years 11 mo revealed
a height of 115.6 cm (5th–10th percentile), a weight of
21.4 kg (5th percentile), and a head circumference of 52
cm (50th–75th percentile). The patient showed high my-
opia and astigmatism, a low frontal hairline with right
upsweep, forehead hypertrichosis, and bushy eyebrows
without frank synophrys. He was also noted to have
surgically improved ptosis and slight epicanthal folds, a
broad nasal bridge with mild hypertelorism (measured
at 1.5 SD at age 21 mo), downslanting palpebral ﬁs-
sures, downturned corners of the mouth, prominent but
normal-sized ears with superior helices sagging down-
ward, slight ﬁfth-ﬁnger clinodactyly, branched trans-
verse palmar crease of right hand, mild bilateral syn-
dactyly of the second and third toes, hypertrichosis of
his thighs and legs, and mild hypotonia. Deep tendon
reﬂexes were normal.
The patient’s clinical presentation, including devel-
opmental delay, growth retardation, and ptosis in com-
bination with the known cytogenetic abnormality, sug-
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Table 1
Selected Features of 3p Deletion Syndrome
Features of 3p Deletion
Syndrome
Affected
Frequencya
(%)
Status in the
Presented Caseb
Developmental delay 86 
Postnatal growth retardation 86 
Ptosis 77 
Low birth weight 73 
Malformed ears 68 
Long philtrum 68 
Broad nasal bridge 64 
Hypotonia 50 
Microcephaly 50 
Micrognathia 50 
Epicanthal folds 41 
Post axial polydactyly 40 
Hyperteliorism 36 
Feeding problems 29 
Clinodactyly 27 
Trigonocephaly 23 
Downturned corners of mouth 24 
Synophoris 18 
Low frontal hairline 14 
a Frequency data is derived from the most recent and largest
case review in the literature (Benini et al. 1999), consisting of 22
patients.
b  p present;  p absent.
Figure 2 Cytogenetic and molecular cytogenetic studies of a de novo t(3;10) translocation. A, G-banded karyotype of the patient’s
lymphocytes showing a t(3p26;10q26) translocation. Arrows highlight the breakpoints on the respective chromosomes, and dotted lines show
the corresponding position on the idiograms. 10/10 metaphase spreads examined showed the identical translocation. B, BAC probe 299N3
(red) spanning the chromosome 3p breakpoint. Hybridization signals are seen on both normal and derivative chromosomes 3. A third red
hybridization signal is also seen on the derivative chromosome 10, as a result of the breakpoint transecting the region corresponding to the
experimental probe. A control probe (green) maps to the q arm of chromosome 3. C, Probe 355F22 (red) spanning the chromosome 10q
breakpoint. Hybridization signals are present on the normal and derivative chromosomes 10. A third red signal is seen on the telomeric region
of chromosome 3. Control probes (green) map to the short arm of chromosome 3. D, Subtelomeric FISH results are shown. Chromosome 10
probes are in the left box—the normal (nl) chromosome 10 with both green and red probes, the derivative (der) 10 with only a green probe,
and the derivative chromosome 3 with only the red probe are shown. The box on the right shows chromosome 3 probes, with the normal
chromosome showing both red and green probes, the derivative 3 showing only the red probe, and the derivative 10 showing only the green
probe.
gested a diagnosis of 3p deletion syndrome (table 1).
Those physical signs not present in this case, such as
trigonocephaly, microcephaly, and micrognathia, are not
ubiquitous ﬁndings in other reported cases in the liter-
ature. The patient’s particular cognitive ﬁndings are mir-
rored in at least one other case, described by Angeloni
et al. (1999), in which the patient was found to have a
full scale IQ in the borderline range with what appeared
to be signiﬁcant weaknesses in adaptive functioning. In
addition, a marked delay in early language acquisition,
as is seen in the present case, frequently has been noted
anecdotally. However, a more detailed comparison of
CT’s cognitive ﬁndings with other reported cases is not
possible, as a result of the informal descriptions of de-
velopmental delay that characterize the 3p deletion syn-
drome literature. What is apparent is that phenotypic
variability in all aspects of the syndrome appears to be
the rule rather than the exception. Moreover, genotype/
phenotype relationships are not straightforward. For in-
stance, as noted, there is a strong relationship between
terminal deletions involving more proximal regions of
chromosome 3 and cardiac ﬁndings (Brand et al. 1987;
Phipps et al. 1994; Drumheller et al. 1996; Green et al.
2000). In contrast, the range and severity of dysmor-
phology and developmental delay may differ markedly
in patients with similar, or even identical, deletions of
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Table 2
BAC Probes Investigated Using FISH
BAC ID Base Positiona Chromosomal Band
Location Relative
to Breakpoint
RP11-1082A18 chr3:10,298,689-10,516,466 3p25.3 Centromeric
RP11-572M14 chr3:10,011,785-10,180,797 3p25.3 Centromeric
RP11-1020A11 chr3:9,778,862-9,995,772 3p25.3 Centromeric
RP11-19E8 chr3:8,917,083-9,067,340 3p25.3 Centromeric
RP11-128A5 chr3:8,686,926-8,857,271 3p25.3 Centromeric
RP11-34L16 chr3:8,442,935-8,594,857 3p25.3 Centromeric
RP11-470E10 chr3:7,841,368-8,025,425 3p26.1 Centromeric
RP11-507D6 chr3:6,997,984-7,199,514 3p26.1 Centromeric
RP11-318I14 chr3:6,283,022-6,437,405 3p26.1 Centromeric
RP11-161L3 chr3:5,744,835-5,909,633 3p26.1 Centromeric
RP11-129J10 chr3:5,027,803-5,180,950 3p26.1 Centromeric
RP11-453A3 chr3:4,158,926-4,329,972 3p26.1 Centromeric
RP11-245A6 chr3:3,545,257-3,707,298 3p26.2 Centromeric
RP11-198P17 chr3:2,928,181-3,117,274 3p26.2 Centromeric
RP11-94M9 chr3:2,804,247-2,975,122 3p26.2 Centromeric
RP11-785A7 chr3:2,690,183-2,862,993 3p26.2–3p26.3 Centromeric
RP11-82O3 chr3:2,566,282-2,742,197 3p26.3 Centromeric
RP11-63O1 chr3:2,443,361-2,617,387 3p26.3 Centromeric
RP11-211K13 chr3:2,307,996-2,470,413 3p26.3 Centromeric
RP11-762O12 chr3:2,287,581-2,441,071 3p26.3 Centromeric
RP11-299N3 chr3:2,181,279-2,367,269 3p26.3 Spanning
RP11-129K1 chr3:2,132,133-2,290,752 3p26.3 Spanning
RP11-176P14 chr3:2,021,987-2,193,951 3p26.3 Telomeric
RP11-416N8 chr3:1,244,095-1,420,317 3p26.3 Telomeric
RP11-392M7 chr3:1,064,436-1,252,749 3p26.3 Telomeric
RP11-114K9 chr3:333,643-518,322 3p26.3 Telomeric
RP11-306H5 chr3:159,323-343,406 3p26.3 Telomeric
RP11-338L11 chr10:116,448,883-116,645,816 10q25.3 Centromeric
RP11-169K19 chr10:117,157,040-117,301,164 10q25.3 Centromeric
RP11-96N16 chr10:117,471,461-117,637,580 10q25.3 Centromeric
RP11-295023 chr10:117,733,868-117,949,898 10q25.3 Centromeric
RP11-498B4 chr10:118,011,104-118,209,364 10q25.3 Centromeric
RP11-5G18 chr10:118,364,598-118,528,414 10q25.3–10q26.11 Centromeric
RP11-328K15 chr10:119,130,080-119,172,006 10q26.11 Centromeric
RP11-355F22 chr10:119,170,007-119,301,205 10q26.11 Spanning
RP11-136I7 chr10:119,181,243-119,340,828 10q26.11 Spanning
RP11-280F22 chr10:119,299,202-119,400,731 10q26.11 Telomeric
RP11-3H12 chr10:119,316,263-119,394,906 10q26.11 Telomeric
RP11-354M20 chr10:119,398,732-119,592,400 10q26.11 Telomeric
a Derived from the July 2003 freeze of the Human Genome Project.
the regions telomeric to 3p25.3 (Tazelaar et al. 1991;
Knight et al. 1995; Benini et al. 1999).
Molecular studies were undertaken to ﬁne map the
(3;10) translocation using FISH, as described elsewhere
(Lichter et al. 1990). Bacterial artiﬁcial chromosomes
(BACs) corresponding to the observed cytogenetic bands
involved in the apparently balanced translocation were
identiﬁed using the UCSC genome browser and obtained
from an RPCI-11 (Roswell Park Cancer Institute) li-
brary. These probes were hybridized to metaphase
spreads consisting of the patient’s lymphocytes. Several
probes mapping centromeric and telomeric to the trans-
location breakpoints on both chromosomes were iden-
tiﬁed (table 2). Subsequent to the identiﬁcation of BACs
mapping on both sides of the translocation breakpoint
on each chromosome, BACs within the translocation
intervals were used, eventually identifying probes span-
ning both the chromosome 3 and 10 breakpoints (ﬁgs.
2 and 3). Two BACs spanning the chromosome 3 break-
point, RPCI-11 299N33 and RPCI-11 121K9, were
found to map in their entirety in the ﬁrst intron of the
gene Contactin 4 (CNTN4 [MIM 607280]) (ﬁg. 3), es-
tablishing that the translocation breakpoint disrupted
the gene within the 5′ UTR of the mature CNTN4
mRNA. Importantly, CNTN4 maps both within the
minimal candidate region for 3p deletion syndrome de-
ﬁned by Cargile et al. (2002) and within a 6.7-cM region
found linked to nonspeciﬁc mental retardation in large
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Figure 3 Diagram of chromosomes 3 and 10 breakpoints. A, Telomeric region of chromosome 3 from 3p26.1 to 3p26.3, represented by
the grey and white bar at the top of the diagram. Relevant STS markers are in black text, and known genes from the RefSeq database are in
blue text. The region corresponding to CNTN4 is pictured as a blue shaded rectangle. Distances noted were derived from the July 2003 freeze
of the Human Genome Project and include: (1) the 1.69 Mb-interval from the 3′-most exon of CHL1 to exon 1 of CNTN4; (2) the 0.69-Mb
interval from the 3′-most exon of CNTN6 to exon 1 of CNTN4; (3) the 4.5-Mb interval deﬁned by Cargile et al. (2002) as the smallest
interstitial deletion identiﬁed in a 3p deletion syndrome case; and (4) the 6.7-cM interval identiﬁed by Higgins et al. (2002) in a large pedigree
affected with nonspeciﬁc mental retardation ( at marker D3S3050). The bar below the genomic interval shows detail of the region,Z p 9.18max
including exons of CNTN4 (in red). Selected BACs are noted as dark horizontal bars beneath. The breakpoint interval is shown as a red
rectangle. The position of each BAC probe relative to the breakpoint on chromosome 3 is indicated below the RPCI-11 library identiﬁer. The
distance for the entire genomic interval corresponding to CNTN4 is indicated below the thin black line. B, Chromosome 10 in the region from
10q25.3-10q26.12, represented by the grey and white bar at the top of the diagram. Known genes from the RefSeq database are noted in blue.
The 0.46-Mb distance between the 3′-most exon of EMX2 and the 5′-most exon of Rab11-FIP2 was determined by the July 2003 freeze of the
Human Genome Project. The lower bar shows details of the interval, with the relative position of known genes in the region in blue text. The
breakpoint region is highlighted with a red rectangle. No known genes or spliced ESTs were identiﬁed on the BAC spanning the chromosome
10 breakpoint. BACs from the region are identiﬁed as dark horizontal lines below the genomic region, with their position relative to the
breakpoint on chromosome 10 noted below their RPCI identiﬁers.
kindred ( at marker D3S3050) (Higgins etZ p 9.18max
al. 2000) (ﬁg. 3A).
BACs RPCI-11 355F22 (ﬁgs. 2 and 3) and RPCI-11
136I7 were found to span the chromosome 10 trans-
location breakpoint. This chromosome segment lies
within a gene-poor region in the band 10q26.11(ﬁg. 3B).
No known or predicted transcripts or spliced ESTs were
identiﬁed on these clones with the use of the UCSC ge-
nome browser. Five distinct ESTs without canonical
splice sites were mapped to the BAC. Efforts to extend
these fragments in silicowith the use of the BLAST server
at the National Center for Biotechnology Information
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were unsuccessful, and four of these ﬁve fragments
showed no signiﬁcant homology to other human ESTs
or known genes. One region at the far telomeric extent
of BAC 355F22 contained a block of 444 bp of DNA
showing 195% homology at the nucleotide level to the
tyrosine 3-monooxygenase/tryptophan 5-monooxygen-
ase activation protein, theta polypeptide (YWHAQ [ac-
cession number BC050601]) on chromosome 2 as well
as the YWHAQ pseudogene 2 on chromosome 22 (ac-
cession number NM_006826). No additional sequences
with homology to YWHAQ were identiﬁed in the chro-
mosome 10 interval via BLAST or BLAT searches. These
analyses do not exclude the possibility of a rare tran-
script mapping to the 10q breakpoint region. However,
the characteristic physical features in this case point to
the chromosome 3 region as the proximate cause of the
patient’s presentation.
Additional FISH studies were undertaken to evaluate
the regions telomeric and centromeric to the 3p trans-
location (table 2). These resulted in no evidence of a
deletion. Subtelomeric FISH with the use of commer-
cially available probes was also performed to conﬁrm
the integrity of the terminal regions of the normal and
derivative chromosomes 3 and 10 (ﬁg. 2D). FISH map-
ping of BACs corresponding to the two closest tran-
scripts on the telomeric aspect of the breakpoint, CHL1
(Close Homologue of L1, also known as CALL [MIM
607416]) and CNTN6 (MIM 607220), each showed the
expected pattern of two hybridization signals, and direct
sequencing of CNTN4 in the patient demonstrated no
mutations in the coding regions of the remaining, intact
transcript (data not shown).
The ﬁnding of disruption of CNTN4 is of particular
interest as this gene encodes a neuronal adhesion mol-
ecule that is a member of the immunoglobulin (Ig)
superfamily of genes. Similar to other members of
the contactin family, which includes F3/F11/contac-
tin (MIM 600316), TAG-1 (CNTN2 [MIM 190197]),
BIG-1 (CNTN3 [MIM 601325]), NB-2 (CNTN5
[MIM 607219]), and NB-3 (CNTN6), full-length
CNTN4 consists of six immunoglobulin domains and
four ﬁbronectin III (FNIII) domains and is anchored to
the cell membrane via a glycosylphosphatidyl-inositol
(GPI) domain. This family of proteins have been shown
to be involved in axon growth, guidance, and fascicu-
lation (Yoshihara et al. 1995; Ogawa et al. 1996; Saito
et al. 1998; Kamei et al. 2000) and have been proposed
to have a role in synaptic plasticity (Murai et al. 2002).
A speciﬁc role for CNTN4 in neuronal development has
not yet been clariﬁed. However, knockouts of homolo-
gous neuronal adhesion molecules in mouse have re-
sulted in viable mutants demonstrating morphological,
neurological, and behavioral abnormalities (Berglund et
al. 1999; Montag-Sallaz et al. 2002; Montag-Sallaz et
al. 2003; Rolf et al. 2003).
At present, three isoforms of CNTN4 are described
in the RefSeq database at NCBI. The identiﬁed break-
point in this case disrupts only the longest variant which
is highly expressed in human brain, particularly in cer-
ebellum, thalamus, amygdala, and cerebral cortex (Ka-
mei et al. 2000; Zeng et al. 2002). An intermediate-sized
isoform, consisting of three Ig domains and three FNIII
domains, has not been found to be expressed in the CNS
(Kamei et al. 2000; Zeng et al. 2002; Hansford et al.
2003). A third, markedly truncated variant lacking all
six Ig domains and two of the four FNIII domains has
been shown to have low levels of expression in the brain,
on the basis of northern blot and RT-PCR analysis (Zeng
et al. 2002).
Given the inaccessibility of the relevant tissue, wewere
not able to test directly whether the translocation altered
expression of the short brain-expressed variant, despite
that transcript remaining structurally intact. Several
characteristics of the full-length isoform, however, point
to the clearly disrupted variant as the key determinant
in the present case, irrespective of the status of the al-
ternative transcript. First, the long variant is the only
known isoform that codes for six Ig-like domains and
four FNIII domains, reﬂecting the canonical structure of
CNTN proteins. Studies of the contactin gene family
have revealed a complex pattern of homophilic and het-
erophilic interactions that are required for axon growth
and pathﬁnding. Such studies demonstrate that these es-
sential functions are mediated by the combination and
juxtaposition of multiple Ig and FNIII domains. Second,
these neuronal adhesion molecules demonstrate highly
regulated temporal and spatial expression patterns in the
CNS. For this reason, the disruption of the regulatory
region of the predominant brain-expressed isoform rea-
sonably would be expected to have signiﬁcant functional
consequences. Third, the smaller brain-expressed vari-
ant, CNTN4a, demonstrates low levels of expression
that are conﬁned to the cerebral cortex, thus minimally
overlapping with that of the long isoform (Zeng et al.
2002). These factors in combination with the lack of all
Ig and several FNIII domains suggest that this truncated
gene product would be a poor candidate to compensate
for disruption of the full-length isoform. Finally, the clin-
ical overlap in this case with ﬁndings from cases of frank
deletion of the terminal region of chromosome 3p sup-
ports the hypothesis that the interruption of the long
variant alone is sufﬁcient to result in functional hap-
loinsufﬁciency at this locus.
The region telomeric to the disrupted CNTN4 gene
contains CNTN6 and CHL1, both neuronal cell adhe-
sion molecules that also contain Ig and FNIII domains
(ﬁg. 3). Of note, a patient with nonspeciﬁc mental re-
tardation and a balanced translocation disruptingCHL1
was described elsewhere (Frints et al. 2003). This patient
was not found to have any other physical abnormalities
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associated with 3p deletion syndrome, and the trans-
location also involved the X chromosome, though no
transcript was identiﬁed at that breakpoint. Analyses of
CHL1 knockout mice, in this study and in others, have
identiﬁed anomalies in axonal organization in various
brain regions, as well as subtle behavioral abnormalities
in homozygous null animals (Montag-Sallaz et al. 2002,
2003; Frints et al. 2003).
Given the proximity of these brain-expressed mole-
cules with similar structures and putative functions, it
is conceivable that the chromosomal rearrangement
leading to disruption ofCNTN4 could also bemediating
functional consequences for neighboring transcripts and,
thereby, leading to the observed phenotype. Although
the possibility of position effect cannot be excluded on
the basis of current data (State et al. 2003), the direct
disruption of the CNTN4 transcript and the genomic
distances separatingCNTN6 andCHL1 from the break-
point (∼0.7 Mb and ∼1.7Mb, respectively) suggest that
the most likely effect of the rearrangement is onCNTN4
function. Moreover, two additional lines of evidence
support a speciﬁc role for CNTN4 in conferring the
observed phenotype. First, in the single reported case of
a translocation disrupting CHL1, the patient did not
show dysmorphic features consistent with 3p deletion
syndrome (Frints et al. 2003), and, second, the 3p min-
imal candidate region (Cargile et al. 2002) includes the
CNTN4 transcript, but not CNTN6 and CHL1 (ﬁg.
3A), suggesting that position effect would have to be
invoked as an explanation in both the interstitial deletion
and translocation cases.
Our ﬁndings strongly suggest that disruption of a sin-
gle copy of CNTN4 is sufﬁcient to confer key aspects
of the 3p deletion syndrome phenotype, including de-
velopmental delay. Thus, CNTN4 is one of a relatively
small number of autosomal genes identiﬁed as contrib-
uting to cognitive deﬁcits in a contiguous-gene syn-
drome. It is interesting to note that many features of a
presumed multigene phenotype are manifested as the
result of the disruption of only a single transcript. This
ﬁnding provides a rationale for mutation screening of
CNTN4 in selected patients with developmental delay
and dysmorphic features who have normal karyotypes.
Although, in the present case, there appears to be a
strong relationship between alterations in CNTN4 ex-
pression and characteristic physical ﬁndings, nonethe-
less, it is noteworthy that a previous analysis of an ex-
tended pedigree identiﬁed evidence for a recessive locus
conferring nonspeciﬁc mental retardation within a 7-cM
region containing CNTN4 (Higgins et al. 2000). On the
basis of the present ﬁndings, this gene should certainly
be considered a candidate transcript in the linkage
interval. Finally, it is particularly interesting that the pa-
tient’s developmental difﬁculties involve notable weak-
nesses in nonverbal aspects of learning as well as a delay
in language acquisition. The identiﬁcation of a likely
etiological role for CNTN4 in these types of human
cognitive deﬁcits suggests that further studies of its
expression and speciﬁc functions in the CNS are
warranted.
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